{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:44:37Z","timestamp":1792194277779,"version":"4.4.0"},"reference-count":177,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,6,23]],"date-time":"2023-06-23T00:00:00Z","timestamp":1687478400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","award":["2022XD023"],"award-info":[{"award-number":["2022XD023"]}],"id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Nonalcoholic fatty liver disease (NAFLD) has become one of the most common chronic liver diseases in the world. The risk factor for NAFLD is often considered to be obesity, but it can also occur in people with lean type, which is defined as lean NAFLD. Lean NAFLD is commonly associated with sarcopenia, a progressive loss of muscle quantity and quality. The pathological features of lean NAFLD such as visceral obesity, insulin resistance, and metabolic inflammation are inducers of sarcopenia, whereas loss of muscle mass and function further exacerbates ectopic fat accumulation and lean NAFLD. Therefore, we discussed the association of sarcopenia and lean NAFLD, summarized the underlying pathological mechanisms, and proposed potential strategies to reduce the risks of lean NAFLD and sarcopenia in this review.<\/jats:p>","DOI":"10.3389\/fendo.2023.1217249","type":"journal-article","created":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T18:38:00Z","timestamp":1687631880000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":43,"title":["Lean nonalcoholic fatty liver disease and sarcopenia"],"prefix":"10.3389","volume":"14","author":[{"given":"Milian","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,6,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgac321","article-title":"Global prevalence and clinical characteristics of metabolic-associated fatty liver disease: a meta-analysis and systematic review of 10 739 607 individuals","volume":"107","author":"Chan","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2020.10.046","article-title":"Impact of the new definition of metabolic associated fatty liver disease on the epidemiology of the disease","volume":"19","author":"Wong","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30908","article-title":"Lean nafld: a distinct entity shaped by differential metabolic adaptation","volume":"71","author":"Chen","year":"2020","journal-title":"Hepatology"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-020-09621-1","article-title":"Lean nafld: an underrecognized and challenging disorder in medicine","volume":"22","author":"Maier","year":"2021","journal-title":"Rev Endocr Metab Disord"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.14218\/JCTH.2016.00068","article-title":"Non-alcoholic fatty liver disease in lean subjects: characteristics and implications","volume":"5","author":"Kumar","year":"2017","journal-title":"J Clin Transl Hepatol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.14218\/JCTH.2022.00204","article-title":"Nonalcoholic fatty liver disease in Lean\/Nonobese and obese individuals: a comprehensive review on prevalence, pathogenesis, clinical outcomes, and treatment","volume":"11","author":"Patel","year":"2023","journal-title":"J Clin Transl Hepatol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of nafld worldwide: a systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(20)30077-7","article-title":"Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"5","author":"Ye","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-021-10147-0","article-title":"The metabolic profiles and body composition of lean metabolic associated fatty liver disease","volume":"15","author":"Cheng","year":"2021","journal-title":"Hepatol Int"},{"key":"B10","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of nafld and Nash: trends, predictions, risk factors and prevention","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/cld.930","article-title":"Nafld in lean asians","volume":"16","author":"Eslam M","year":"2021","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"B12","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1055\/s-0038-1677517","article-title":"Nash In lean individuals","volume":"39","author":"Younes","year":"2019","journal-title":"Semin Liver Dis"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2016.08.028","article-title":"Nonobese fatty liver disease","volume":"15","author":"Kim","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2014.08.037","article-title":"Prevalence of suspected nonalcoholic fatty liver disease in Hispanic\/Latino individuals differs by heritage","volume":"13","author":"Kallwitz","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/apt.12038","article-title":"Non-alcoholic fatty liver disease (Nafld) is associated with low level of physical activity: a population-based study","volume":"36","author":"Gerber","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"B16","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1136\/flgastro-2014-100432","article-title":"Non-alcoholic fatty liver disease is associated with higher levels of objectively measured sedentary behaviour and lower levels of physical activity than matched healthy controls","volume":"6","author":"Hallsworth","year":"2015","journal-title":"Frontline Gastroenterol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1586\/17474124.2015.1075392","article-title":"The benefits of exercise for patients with non-alcoholic fatty liver disease","volume":"9","author":"Keating","year":"2015","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.3390\/biomedicines9101346","article-title":"Non-alcoholic fatty liver disease in lean and non-obese individuals: current and future challenges","volume":"9","author":"Kuchay","year":"2021","journal-title":"Biomedicines"},{"key":"B19","article-title":"A. study and comparison of metabolic profile of lean and obese subjects with non alcoholic fatty liver disease","volume":"68","author":"Parth","year":"2020","journal-title":"J Assoc Physicians India"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2022.11.019","article-title":"Mortality and liver-related events in lean versus non-lean nonalcoholic fatty liver disease: a systematic review and meta-analysis","author":"Ha","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.2081","article-title":"Outcomes of subjects who are lean, overweight or obese with nonalcoholic fatty liver disease: a cohort study in China","volume":"6","author":"Lan","year":"2022","journal-title":"Hepatol Commun"},{"key":"B22","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/hep.28697","article-title":"Histological severity and clinical outcomes of nonalcoholic fatty liver disease in nonobese patients","volume":"65","author":"Leung","year":"2017","journal-title":"Hepatology"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-018-9916-4","article-title":"Lean non-alcoholic fatty liver disease (Lean nafld): characteristics, metabolic outcomes and risk factors from a 7-year prospective, community cohort study from Sri Lanka","volume":"13","author":"Niriella","year":"2019","journal-title":"Hepatol Int"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i47.17932","article-title":"Lean-Non-Alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population","volume":"20","author":"Feng","year":"2014","journal-title":"World J Gastroenterol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000329","article-title":"Lean individuals with nafld have more severe liver disease and poorer clinical outcomes (Nash-Co study)","author":"Nabi","year":"2023","journal-title":"Hepatology"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22350","article-title":"Visceral fat: a key mediator of steatohepatitis in metabolic liver disease","volume":"48","author":"van der Poorten","year":"2008","journal-title":"Hepatology"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.15353","article-title":"A review of non-alcoholic fatty liver disease in non-obese and lean individuals","volume":"36","author":"Ahadi","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/oby.2008.555","article-title":"Fat depot-specific impact of visceral obesity on adipocyte adiponectin release in women","volume":"17","author":"Drolet","year":"2009","journal-title":"Obes (Silver Spring)"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2002-020635","article-title":"Differential regulation of adiponectin secretion from cultured human omental and subcutaneous adipocytes: effects of insulin and rosiglitazone","volume":"87","author":"Motoshima","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1080\/00365520802588133","article-title":"Nutritional investigation of non-obese patients with non-alcoholic fatty liver disease: the significance of dietary cholesterol","volume":"44","author":"Yasutake","year":"2009","journal-title":"Scand J Gastroenterol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2020.101200","article-title":"Sarcopenia - molecular mechanisms and open questions","volume":"65","author":"Wiedmer","year":"2021","journal-title":"Ageing Res Rev"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12483","article-title":"Sarcopenia: a time for action. an scwd position paper","volume":"10","author":"Bauer","year":"2019","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0b013e318293a825","article-title":"Sarcopenia as a prognostic index of nutritional status in concurrent cirrhosis and hepatocellular carcinoma","volume":"47","author":"Meza-Junco","year":"2013","journal-title":"J Clin Gastroenterol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/S1262-3636(05)73648-X","article-title":"Insulin resistance: a contributing factor to age-related muscle mass loss","author":"Guillet C","year":"2005","journal-title":"Diabetes Metab"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28376","article-title":"Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: nationwide surveys (Knhanes 2008-2011)","volume":"63","author":"Lee","year":"2016","journal-title":"Hepatology"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14852","article-title":"Sarcopenia in nonalcoholic fatty liver disease and all-cause and cause-specific mortality in the united states","volume":"41","author":"Kim","year":"2021","journal-title":"Liver Int"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.7570\/jomes.2019.28.2.129","article-title":"Sarcopenia is significantly associated with presence and severity of nonalcoholic fatty liver disease","volume":"28","author":"Chung","year":"2019","journal-title":"J Obes Metab Syndr"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2020.100171","article-title":"Contribution of sarcopenia and physical inactivity to mortality in people with non-alcoholic fatty liver disease","volume":"2","author":"Golabi","year":"2020","journal-title":"JHEP Rep"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13889","article-title":"Sarcopenia is associated with severe liver fibrosis in patients with non-alcoholic fatty liver disease","volume":"45","author":"Petta","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/5016091","article-title":"The relationship between nafld and sarcopenia in elderly patients","volume":"2018","author":"Zhai","year":"2018","journal-title":"Can J Gastroenterol Hepatol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000001397","article-title":"Associations between sarcopenia and nonalcoholic fatty liver disease and advanced fibrosis in the USA","volume":"31","author":"Wijarnpreecha","year":"2019","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1111\/liv.14719","article-title":"Muscle alterations are independently associated with significant fibrosis in patients with nonalcoholic fatty liver disease","volume":"41","author":"Hsieh","year":"2021","journal-title":"Liver Int"},{"key":"B43","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.cgh.2022.01.020","article-title":"Myosteatosis, but not sarcopenia, predisposes nafld subjects to early steatohepatitis and fibrosis progression","volume":"21","author":"Hsieh","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2023.02.013","article-title":"Sarcopenia among patients with nonalcoholic fatty liver disease (Nafld) is associated with advanced fibrosis","author":"Harring","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ageing\/afy169","article-title":"Sarcopenia: revised European consensus on definition and diagnosis","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Age Ageing"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1080\/17474124.2018.1534586","article-title":"Sarcopenia and chronic liver diseases","volume":"12","author":"Hsu","year":"2018","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-Analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"key":"B48","doi-asserted-by":"publisher","first-page":"364","DOI":"10.3390\/nu10030364","article-title":"Association between sarcopenia and metabolic syndrome in middle-aged and older non-obese adults: a systematic review and meta-analysis","volume":"10","author":"Zhang","year":"2018","journal-title":"Nutrients"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1002\/cld.900","article-title":"Association of sarcopenia and nafld an overeview","volume":"16","author":"Li AA","year":"2020","journal-title":"Clin Liver Dis (Hoboken)"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/2229139","article-title":"The association of sarcopenia and visceral obesity with lean nonalcoholic fatty liver disease in Chinese patients with type 2 diabetes mellitus","volume":"2022","author":"Zhang","year":"2022","journal-title":"J Diabetes Res"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2022.0358","article-title":"Interaction between sarcopenia and nonalcoholic fatty liver disease","volume":"29","author":"Joo","year":"2023","journal-title":"Clin Mol Hepatol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.9258","article-title":"Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma","volume":"100","author":"Harimoto","year":"2013","journal-title":"Br J Surg"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.2478\/jtim-2019-0023","article-title":"Effect of weight reduction on histological activity and fibrosis of lean nonalcoholic steatohepatitis patient","volume":"7","author":"Alam","year":"2019","journal-title":"J Transl Int Med"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1097\/MEG.0000000000002530","article-title":"Mechanisms of non-alcoholic fatty liver disease development in normal-weight individuals","volume":"35","author":"Muriel","year":"2023","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.14360","article-title":"Lean non-alcoholic fatty liver disease patients had comparable total caloric, carbohydrate, protein, fat, iron, sleep duration and overtime work as obese non-alcoholic fatty liver disease patients","volume":"34","author":"Li","year":"2019","journal-title":"J Gastroenterol Hepatol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.5812\/hepatmon.44962","article-title":"Dietary determinants of non-alcoholic fatty liver disease in lean and non-lean adult patients: a population-based study in Shiraz, southern Iran","volume":"17","author":"Honarvar","year":"2017","journal-title":"Hepatitis Monthly"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0b013e3182779d49","article-title":"Nonalcoholic fatty liver disease in lean individuals in the united states","volume":"91","author":"Younossi","year":"2012","journal-title":"Med (Baltimore)"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1126\/science.1204265","article-title":"Human fatty liver disease: old questions and new insights","volume":"332","author":"Cohen","year":"2011","journal-title":"Science"},{"key":"B59","doi-asserted-by":"publisher","first-page":"20535","DOI":"10.1038\/s41598-022-24736-y","article-title":"Glut4 translocation and dispersal operate in multiple cell types and are negatively correlated with cell size in adipocytes","volume":"12","author":"Koester","year":"2022","journal-title":"Sci Rep"},{"key":"B60","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/s42003-021-02491-6","article-title":"A xanthene derivative, Ds20060511, attenuates glucose intolerance by inducing skeletal muscle-specific Glut4 translocation in mice","volume":"4","author":"Furuzono","year":"2021","journal-title":"Commun Biol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20080723","article-title":"Insulin action on glucose transporters through molecular switches, tracks and tethers","volume":"413","author":"Zaid","year":"2008","journal-title":"Biochem J"},{"key":"B62","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1042\/BSR20080105","article-title":"Ready, set, internalize: mechanisms and regulation of Glut4 endocytosis","volume":"29","author":"Antonescu","year":"2009","journal-title":"Biosci Rep"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(14)70034-8","article-title":"Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases","volume":"2","author":"Kalyani","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.13070","article-title":"Hyperglycemia in non-obese patients with type 2 diabetes is associated with low muscle mass: the multicenter study for clarifying evidence for sarcopenia in patients with diabetes mellitus","volume":"10","author":"Sugimoto","year":"2019","journal-title":"J Diabetes Investig"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.50.6.1324","article-title":"Glut4 is reduced in slow muscle fibers of type 2 diabetic patients: is insulin resistance in type 2 diabetes a slow, type 1 fiber disease","volume":"50","author":"Gaster M","year":"2001","journal-title":"Diabetes"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-S302","article-title":"Skeletal muscle insulin resistance is the primary defect in type 2 diabetes","author":"DeFronzo","year":"2009","journal-title":"Diabetes Care"},{"key":"B67","doi-asserted-by":"publisher","first-page":"155595","DOI":"10.1016\/j.metabol.2023.155595","article-title":"Sarcopenic obesity in free-living older adults detected by the espen-easo consensus diagnostic algorithm: validation in an Italian cohort and predictive value of insulin resistance and altered plasma ghrelin profile","author":"Cappellari","year":"2023","journal-title":"Metabolism"},{"key":"B68","doi-asserted-by":"publisher","first-page":"3628","DOI":"10.1038\/s41598-023-30833-3","article-title":"Effects of additive interactions among obesity, visceral adiposity, and sarcopenia on nonalcoholic fatty liver disease","volume":"13","author":"Chung","year":"2023","journal-title":"Sci Rep"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1017\/S1368980015002475","article-title":"Insulin resistance and sarcopenia are closely related to metabolic syndrome in Male and female adolescents","volume":"19","author":"Kawada","year":"2016","journal-title":"Public Health Nutr"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2021.12.013","article-title":"Systems-level analysis of insulin action in mouse strains provides insight into tissue- and pathway-specific interactions that drive insulin resistance","volume":"34","author":"Nelson","year":"2022","journal-title":"Cell Metab"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1590\/1414-431X2020e10782","article-title":"The role of pioglitazone in antioxidant, anti-inflammatory, and insulin sensitivity in a high fat-carbohydrate diet-induced rat model of insulin resistance","volume":"54","author":"Al-Muzafar","year":"2021","journal-title":"Braz J Med Biol Res"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2022.155216","article-title":"Increased plasma fatty acid clearance, not fatty acid concentration, is associated with muscle insulin resistance in people with obesity","volume":"132","author":"Cao","year":"2022","journal-title":"Metabolism"},{"key":"B73","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.3390\/nu15102323","article-title":"Dysregulation of lipid and glucose metabolism in nonalcoholic fatty liver disease","volume":"15","author":"Bhat","year":"2023","journal-title":"Nutrients"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1007\/s00441-020-03251-4","article-title":"Islr regulates skeletal muscle atrophy Via Igf1-Pi3k\/Akt-Foxo signaling pathway","volume":"381","author":"Cui","year":"2020","journal-title":"Cell Tissue Res"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2022.09.020","article-title":"Leptin increases hepatic triglyceride export Via a vagal mechanism in humans","volume":"34","author":"Metz","year":"2022","journal-title":"Cell Metab"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1172\/JCI134165","article-title":"Insulin resistance drives hepatic De novo lipogenesis in nonalcoholic fatty liver disease","volume":"130","author":"Smith","year":"2020","journal-title":"J Clin Invest"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamda.2022.12.002","article-title":"Preserved lower limb muscle mass prevents insulin resistance development in nondiabetic older adults","volume":"24","author":"Seko","year":"2023","journal-title":"J Am Med Directors Assoc"},{"key":"B78","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.3390\/cells9081773","article-title":"Implications of insulin-like growth factor-1 in skeletal muscle and various diseases","volume":"9","author":"Ahmad","year":"2020","journal-title":"Cells"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1002\/jcsm.12760","article-title":"Exogenous insulin-like growth factor 1 attenuates cisplatin-induced muscle atrophy in mice","volume":"12","author":"Sakai","year":"2021","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.108998","article-title":"A low serum igf-1 is correlated with sarcopenia in subjects with type 1 diabetes mellitus: findings from a Post-hoc analysis of the idiamond study","volume":"179","author":"Hata","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"key":"B81","article-title":"Associations of calf inter- and intra-muscular adipose tissue with cardiometabolic health and physical function in community-dwelling older adults","volume":"15","author":"Scott D","year":"2015","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"B82","doi-asserted-by":"publisher","first-page":"10790","DOI":"10.1038\/s41598-021-89039-0","article-title":"Activation of igf-1 pathway and suppression of atrophy related genes are involved in epimedium extract (Icariin) promoted C2c12 myotube hypertrophy","volume":"11","author":"Lin","year":"2021","journal-title":"Sci Rep"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2006.12.024","article-title":"Growth hormone reverses nonalcoholic steatohepatitis in a patient with adult growth hormone deficiency","volume":"132","author":"Takahashi","year":"2007","journal-title":"Gastroenterology"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2002.05641.x","article-title":"Growth hormone plasma levels in nonalcoholic fatty liver disease","volume":"97","author":"Lonardo","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"B85","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1136\/gut.52.6.914","article-title":"Non-alcoholic steatohepatitis and hepatic steatosis in patients with adult onset growth hormone deficiency","volume":"52","author":"Ichikawa","year":"2003","journal-title":"Gut"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2016.08.019","article-title":"Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis","volume":"66","author":"Koo","year":"2017","journal-title":"J Hepatol"},{"key":"B87","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.neuropharm.2011.12.010","article-title":"The adipocyte as an endocrine organ in the regulation of metabolic homeostasis","volume":"63","author":"Harwood","year":"2012","journal-title":"Neuropharmacology"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1038\/nri1937","article-title":"Adipocytokines: mediators linking adipose tissue, inflammation and immunity","volume":"6","author":"Tilg","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.2337\/db14-0796","article-title":"Human adipocytes induce inflammation and atrophy in muscle cells during obesity","volume":"64","author":"Pellegrinelli V","year":"2015","journal-title":"Diabetes"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.2147\/CIA.S78901","article-title":"Monocyte chemoattractant protein-1: a proinflammatory cytokine elevated in sarcopenic obesity","volume":"10","author":"Lim","year":"2015","journal-title":"Clin Interv Aging"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-022-00727-x","article-title":"Insulin sensitive human adipocytes for in vitro studies","volume":"18","author":"Straub","year":"2022","journal-title":"Nat Rev Endocrinol"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1094075","article-title":"Association between body fat and sarcopenia in older adults with type 2 diabetes mellitus: a cross-sectional study","volume":"14","author":"Sun","year":"2023","journal-title":"Front In Endocrinol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"e13583","DOI":"10.1111\/acel.13583","article-title":"Coordination of mitochondrial and lysosomal homeostasis mitigates inflammation and muscle atrophy during aging","volume":"21","author":"Irazoki","year":"2022","journal-title":"Aging Cell"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2015.12.031","article-title":"The role of E3 ubiquitin-ligases murf-1 and mafbx in loss of skeletal muscle mass","volume":"98","author":"Rom","year":"2016","journal-title":"Free Radic Biol Med"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/7436577","article-title":"Mitochondrial ros produced by skeletal muscle mitochondria promote the decisive signal for uprmt activation","volume":"2022","author":"Wang","year":"2022","journal-title":"BioMed Res Int"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.0050110","article-title":"Mitochondrial dysfunction accounts for the stochastic heterogeneity in telomere-dependent senescence","volume":"5","author":"Passos","year":"2007","journal-title":"PloS Biol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"7704","DOI":"10.3390\/ijms21207704","article-title":"Impact of mitophagy and mitochondrial unfolded protein response as new adaptive mechanisms underlying old pathologies: sarcopenia and non-alcoholic fatty liver disease","volume":"21","author":"Urbina-Varela R","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B98","doi-asserted-by":"publisher","first-page":"7128","DOI":"10.3390\/molecules26237128","article-title":"Fermented oyster extract attenuated dexamethasone-induced muscle atrophy by decreasing oxidative stress","volume":"26","author":"Oh","year":"2021","journal-title":"Molecules"},{"key":"B99","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1519\/JPT.0b013e3182a51b11","article-title":"Jump test performance and sarcopenia status in men and women, 55 to 75 years of age","volume":"37","author":"Singh","year":"2014","journal-title":"J Geriatr Phys Ther"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/gls109","article-title":"Sarcopenia definitions considering body size and fat mass are associated with mobility limitations: the framingham study","volume":"68","author":"Dufour","year":"2013","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvac095","article-title":"Adipose and skeletal muscle expression of adiponectin and liver receptor homolog-1 with weight loss and aerobic exercise","volume":"6","author":"Ryan","year":"2022","journal-title":"J Endocr Soc"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1134\/S0006297922110049","article-title":"Adiponectin stimulates apolipoprotein a-1 gene expression in Hepg2 cells Via ampk, ppar\u03b1, and lxrs signaling mechanisms","volume":"87","author":"Tanyanskiy","year":"2022","journal-title":"Biochem (Mosc)"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2022.10.003","article-title":"Synergistic activation of ampk by Adipor1\/2 agonist and inhibitor of edps-ebp interaction recover nafld through enhancing mitochondrial function in mice","volume":"13","author":"Song","year":"2023","journal-title":"Acta Pharm Sin B"},{"key":"B104","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1530\/JOE-21-0388","article-title":"Combined growth hormone and insulin-like growth factor-1 rescues growth retardation in glucocorticoid-treated mdxmice but does not prevent osteopenia","volume":"253","author":"Wood","year":"2022","journal-title":"J Endocrinol"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.00090.2021","article-title":"Deletion of muscle Igf1 exacerbates disuse atrophy weakness in mice","volume":"131","author":"Spradlin","year":"2021","journal-title":"J Appl Physiol (Bethesda Md: 1985)"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-016-4285-0","article-title":"Diet-induced nonalcoholic fatty liver disease is associated with sarcopenia and decreased serum insulin-like growth factor-1","volume":"61","author":"Cabrera","year":"2016","journal-title":"Dig Dis Sci"},{"key":"B107","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.3390\/biomedicines10092253","article-title":"Irisin is related to non-alcoholic fatty liver disease (Nafld)","volume":"10","author":"Kosmalski","year":"2022","journal-title":"Biomedicines"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1210\/me.2014-1353","article-title":"Irisin, a novel myokine, regulates glucose uptake in skeletal muscle cells Via ampk","volume":"29","author":"Lee","year":"2015","journal-title":"Mol Endocrinol"},{"key":"B109","doi-asserted-by":"publisher","first-page":"47","DOI":"10.5603\/EP.a2022.0067","article-title":"Circulating irisin in nonalcoholic fatty liver disease: an updated meta-analysis","volume":"74","author":"Qiu","year":"2023","journal-title":"Endokrynol Pol"},{"key":"B110","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/s12916-019-1364-z","article-title":"Gwas and enrichment analyses of non-alcoholic fatty liver disease identify new trait-associated genes and pathways across emerge network","volume":"17","author":"Namjou","year":"2019","journal-title":"BMC Med"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2016.318","article-title":"Clinical and metabolic characterization of lean Caucasian subjects with non-alcoholic fatty liver","volume":"112","author":"Feldman","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2020.04.058","article-title":"Pnpla3 gene polymorphism and liver- and extrahepatic cancer-related mortality in the united states","volume":"19","author":"Wijarnpreecha","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1186\/s12902-022-01234-w","article-title":"Unique genetic variants of lean nonalcoholic fatty liver disease: a retrospective cohort study","volume":"23","author":"Li","year":"2023","journal-title":"BMC Endocr Disord"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2022.970854","article-title":"Fasting glucose mediates the influence of genetic variants of Sod2 gene on lean non-alcoholic fatty liver disease","volume":"13","author":"Wu","year":"2022","journal-title":"Front Genet"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2019.02.001","article-title":"Whole-exome sequencing identifies a variant in phosphatidylethanolamine n-methyltransferase gene to be associated with lean-nonalcoholic fatty liver disease","volume":"9","author":"Bale","year":"2019","journal-title":"J Clin Exp Hepatol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1249\/MSS.0000000000000889","article-title":"Genetic variant in Acvr2b is associated with lean mass","volume":"48","author":"Klimentidis","year":"2016","journal-title":"Med Sci Sports Exerc"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1038\/bonekey.2012.58","article-title":"Genetic aspects of skeletal muscle strength and mass with relevance to sarcopenia","volume":"1","author":"Roth","year":"2012","journal-title":"Bonekey Rep"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/983424","article-title":"Association between -308 g\/a tnf-\u03b1 polymorphism and appendicular skeletal muscle mass index as a marker of sarcopenia in normal weight obese syndrome","volume":"35","author":"Di Renzo","year":"2013","journal-title":"Dis Markers"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M400884200","article-title":"P53 involvement in the pathogenesis of fatty liver disease","volume":"279","author":"Yahagi","year":"2004","journal-title":"J Biol Chem"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.151.6.1295","article-title":"P53 regulates myogenesis by triggering the differentiation activity of prb","volume":"151","author":"Porrello","year":"2000","journal-title":"J Cell Biol"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/743634","article-title":"Individually tailored screening of susceptibility to sarcopenia using P53 codon 72 polymorphism, phenotypes, and conventional risk factors","volume":"2014","author":"Di Renzo","year":"2014","journal-title":"Dis Markers"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1186\/s12863-017-0470-1","article-title":"Fat mass and obesity associated (Fto) gene influences skeletal muscle phenotypes in non-resistance trained males and elite rugby playing position","volume":"18","author":"Heffernan","year":"2017","journal-title":"BMC Genet"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.14949","article-title":"Lean non-alcoholic fatty liver disease and associated metabolic disturbance: a Saudi Arabian cross-sectional study","volume":"9","author":"Khayyat","year":"2021","journal-title":"Physiol Rep"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1093\/gerona\/62.2.206","article-title":"Alpha-Actinin-3 (Actn3) R577x polymorphism influences knee extensor peak power response to strength training in older men and women","volume":"62","author":"Delmonico","year":"2007","journal-title":"Journals Gerontology Ser A Biol Sci Med Sci"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/87.2.385","article-title":"Vitamin d receptor genotypes influence quadriceps strength in chronic obstructive pulmonary disease","volume":"87","author":"Hopkinson","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1139\/apnm-2014-0346","article-title":"The Actn3 R577x genotype is associated with muscle function in a Japanese population","volume":"40","author":"Kikuchi","year":"2015","journal-title":"Appl Physiol Nutr Metab"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.00817.2004","article-title":"Muscle strength response to strength training is influenced by insulin-like growth factor 1 genotype in older adults","volume":"98","author":"Kostek","year":"2005","journal-title":"J Appl Physiol (Bethesda Md: 1985)"},{"key":"B128","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1007\/s11357-016-9909-y","article-title":"Joint effect of gene-physical activity and the interactions among crp, tnf-\u03b1, and lta polymorphisms on serum crp, tnf-\u03b1 levels, and handgrip strength in community-dwelling elders in Taiwan - tchs-e","volume":"38","author":"Li","year":"2016","journal-title":"Age (Dordrecht Netherlands)"},{"key":"B129","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1055\/s-0030-1267229","article-title":"Ace and Actn3 genotypes in older women: muscular phenotypes","volume":"32","author":"Lima","year":"2011","journal-title":"Int J Sports Med"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2018.05.025","article-title":"Vitamin d receptor gene polymorphisms modify the association of serum 25-hydroxyvitamin d levels with handgrip strength in the elderly in northern China","volume":"57","author":"Xia","year":"2019","journal-title":"Nutr (Burbank Los Angeles County Calif)"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpc.2020.100097","article-title":"The risk of cardiometabolic disorders in lean non-alcoholic fatty liver disease: a longitudinal study","volume":"4","author":"Aneni","year":"2020","journal-title":"Am J Prev Cardiol"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.5009\/gnl210084","article-title":"Cardiovascular risk is elevated in lean subjects with nonalcoholic fatty liver disease","volume":"16","author":"Kim","year":"2022","journal-title":"Gut Liver"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2020.101092","article-title":"Dysregulated lipid metabolism links nafld to cardiovascular disease","volume":"42","author":"Deprince","year":"2020","journal-title":"Mol Metab"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-022-10439-z","article-title":"Presence of sarcopenia identifies a special group of lean nafld in middle-aged and older people","volume":"17","author":"Zhu","year":"2023","journal-title":"Hepatol Int"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1089\/met.2022.0027","article-title":"Relationship between relative grip strength and serum total cholesterol, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, and triglyceride levels in Korean middle-aged or older adults: a panel regression model","volume":"20","author":"Park","year":"2022","journal-title":"Metab Syndr Relat Disord"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.06.038","article-title":"An fxr agonist reduces bile acid synthesis independently of increases in Fgf19 in healthy volunteers","volume":"155","author":"Al-Khaifi","year":"2018","journal-title":"Gastroenterology"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28709","article-title":"Bile acids and nonalcoholic fatty liver disease: molecular insights and therapeutic perspectives","volume":"65","author":"Arab","year":"2017","journal-title":"Hepatology"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-031-26163-3_10","article-title":"Bile acids alter the autophagy and mitogenesis in skeletal muscle cells","volume":"1408","author":"Tacchi","year":"2023","journal-title":"Adv Exp Med Biol"},{"key":"B139","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.3390\/antiox11091706","article-title":"Bile acids induce alterations in mitochondrial function in skeletal muscle fibers","volume":"11","author":"Abrigo","year":"2022","journal-title":"Antioxidants (Basel)"},{"key":"B140","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s40659-023-00431-8","article-title":"Ursodeoxycholic acid induces sarcopenia associated with decreased protein synthesis and autophagic flux","volume":"56","author":"Orozco-Aguilar","year":"2023","journal-title":"Biol Res"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2019.09.002","article-title":"Characterization of biopsy proven non-alcoholic fatty liver disease in healthy non-obese and lean population of living liver donors: the impact of uric acid","volume":"44","author":"Eshraghian","year":"2020","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/5953461","article-title":"Association between serum uric acid to hdl-cholesterol ratio and nonalcoholic fatty liver disease in lean Chinese adults","volume":"2020","author":"Zhang","year":"2020","journal-title":"Int J Endocrinol"},{"key":"B143","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3390\/diseases10030042","article-title":"Nutritional and nutrition-related biomarkers as prognostic factors of sarcopenia, and their role in disease progression","volume":"10","author":"Papadopoulou","year":"2022","journal-title":"Diseases"},{"key":"B144","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s12877-022-02817-x","article-title":"Higher uric acid serum levels are associated with sarcopenia in West China: a cross-sectional study","volume":"22","author":"Liu","year":"2022","journal-title":"BMC Geriatr"},{"key":"B145","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ejim.2017.03.014","article-title":"Higher uric acid serum levels are associated with better muscle function in the oldest old: results from the mugello study","volume":"41","author":"Molino-Lova","year":"2017","journal-title":"Eur J Intern Med"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1016\/j.afos.2022.10.001","article-title":"Association between serum uric acid and relative hand grip strength in comparison with metabolic syndrome components","volume":"8","author":"Yi","year":"2022","journal-title":"Osteoporos Sarcopenia"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.01.020","article-title":"Interactions between the intestinal microbiome and liver diseases","volume":"146","author":"Schnabl","year":"2014","journal-title":"Gastroenterology"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1038\/srep32002","article-title":"Altered fecal microbiota correlates with liver biochemistry in nonobese patients with non-alcoholic fatty liver disease","volume":"6","author":"Wang","year":"2016","journal-title":"Sci Rep"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22848","article-title":"Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease","volume":"49","author":"Miele","year":"2009","journal-title":"Hepatology"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.5604\/01.3001.0010.5494","article-title":"The role of bile acids in glucose metabolism and their relation with diabetes","volume":"16","author":"Alberto Gonz\u00e1lez-Regueiro","year":"2017","journal-title":"Ann Hepatol"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-314307","article-title":"Suppressed hepatic bile acid signalling despite elevated production of primary and secondary bile acids in nafld","volume":"67","author":"Jiao","year":"2018","journal-title":"Gut"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1136\/flgastro-2018-101119","article-title":"Non-alcoholic fatty liver disease (Nafld) in non-obese individuals","volume":"11","author":"Phipps","year":"2020","journal-title":"Frontline Gastroenterol"},{"key":"B153","doi-asserted-by":"publisher","first-page":"lxac014","DOI":"10.1093\/jambio\/lxac014","article-title":"The critical role of gut microbiota dysbiosis in skeletal muscle wasting: a systematic review","volume":"134","author":"Nikkhah","year":"2023","journal-title":"J Appl Microbiol"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1016\/j.archger.2023.105063","article-title":"Relationships between sarcopenia, nutrient intake, and gut microbiota in Chinese community-dwelling older women","volume":"113","author":"Yan","year":"2023","journal-title":"Arch Gerontol Geriatr"},{"key":"B155","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.3390\/nu15051266","article-title":"Bifidobacterium as a potential biomarker of sarcopenia in elderly women","volume":"15","author":"Wang","year":"2023","journal-title":"Nutrients"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1106334","article-title":"Lifestyle intervention reduces risk score for cardiovascular mortality in company employees with pre-diabetes or diabetes mellitus - a secondary analysis of the preford randomized controlled trial with 3 years of follow-up","volume":"14","author":"Brinkmann","year":"2023","journal-title":"Front In Endocrinol"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnu.2014.03.007","article-title":"Muscle contractile and metabolic dysfunction is a common feature of sarcopenia of aging and chronic diseases: from sarcopenic obesity to cachexia","volume":"33","author":"Biolo","year":"2014","journal-title":"Clin Nutr"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2018.08.011","article-title":"Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease","volume":"69","author":"Wong","year":"2018","journal-title":"J Hepatol"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.2147\/CIA.S132940","article-title":"Relationship between sarcopenia and physical activity in older people: a systematic review and meta-analysis","volume":"12","author":"Steffl","year":"2017","journal-title":"Clin Interv Aging"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.3350\/cmh.2022.0358","article-title":"Interaction between sarcopenia and nafld","author":"Joo SK","year":"2023","journal-title":"Clin Mol Hepatol"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1002\/hep.23129","article-title":"Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss","volume":"50","author":"Johnson","year":"2009","journal-title":"Hepatology"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1177\/0031512519860637","article-title":"Circuit training improvements in Korean women with sarcopenia","volume":"126","author":"Jung","year":"2019","journal-title":"Percept Mot Skills"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1111\/ggi.13499","article-title":"Effect of whey protein supplementation after resistance exercise on the muscle mass and physical function of healthy older women: a randomized controlled trial","volume":"18","author":"Mori","year":"2018","journal-title":"Geriatr Gerontol Int"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1111\/ggi.13547","article-title":"Effects of branched-chain amino acids and vitamin d supplementation on physical function, muscle mass and strength, and nutritional status in sarcopenic older adults undergoing hospital-based rehabilitation: a multicenter randomized controlled trial","volume":"19","author":"Takeuchi","year":"2019","journal-title":"Geriatr Gerontol Int"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1080\/07315724.2022.2025546","article-title":"Essential amino acid and tea catechin supplementation after resistance exercise improves skeletal muscle mass in older adults with sarcopenia: an open-label, pilot, randomized controlled trial","volume":"42","author":"Tokuda","year":"2023","journal-title":"J Am Nutr Assoc"},{"key":"B166","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.3390\/nu14122458","article-title":"Effects of Internet-based nutrition and exercise interventions on the prevention and treatment of sarcopenia in the elderly","volume":"14","author":"Wang","year":"2022","journal-title":"Nutrients"},{"key":"B167","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nut.2018.05.028","article-title":"Effects of a leucine-enriched amino acid supplement on muscle mass, muscle strength, and physical function in post-stroke patients with sarcopenia: a randomized controlled trial","volume":"58","author":"Yoshimura","year":"2019","journal-title":"Nutrition"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afy179","article-title":"Effects of exercise and nutrition supplementation in community-dwelling older Chinese people with sarcopenia: a randomized controlled trial","volume":"48","author":"Zhu","year":"2019","journal-title":"Age Ageing"},{"key":"B169","article-title":"Translational studies in older men using testosterone to treat sarcopenia","volume":"125","author":"Urban","year":"2014","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1111\/jgs.14927","article-title":"Treatment of sarcopenia with bimagrumab: results from a phase ii, randomized, controlled, proof-of-Concept study","volume":"65","author":"Rooks","year":"2017","journal-title":"J Am Geriatr Soc"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1038\/oby.2001.81","article-title":"Obesity and sarcopenia after menopause are reversed by sex hormone replacement therapy","volume":"9","author":"S\u00f8rensen","year":"2001","journal-title":"Obes Res"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.4103\/2231-4040.90879","article-title":"The peroxisome proliferator-activated receptor: a family of nuclear receptors role in various diseases","volume":"2","author":"Tyagi","year":"2011","journal-title":"J Adv Pharm Technol Res"},{"key":"B173","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.cgh.2017.12.001","article-title":"Response to pioglitazone in patients with nonalcoholic steatohepatitis with vs without type 2 diabetes","volume":"16","author":"Bril","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1097\/MED","article-title":"An update on Sglt2 inhibitors for the treatment of diabetes mellitus","volume":"24","author":"Daniel S Hsia","year":"2017","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.15580","article-title":"The effects of dapagliflozin on hepatic and visceral fat in type 2 diabetes patients with non-alcoholic fatty liver disease","volume":"36","author":"Phrueksotsai","year":"2021","journal-title":"J Gastroenterol Hepatol"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9149(98)00010-1","article-title":"Consensus for the use of fibrates in the treatment of dyslipoproteinemia and coronary heart disease","volume":"81","author":"Fruchart JC","year":"1998","journal-title":"Fibrate Consensus Group Am J Cardiol"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.1111\/fcp.12597","article-title":"Protective effect of fenofibrate against high-Fat-High-Fructose diet induced non-obese nafld in rats","volume":"35","author":"Abdelmoneim","year":"2021","journal-title":"Fundam Clin Pharmacol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1217249\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T18:38:07Z","timestamp":1687631887000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1217249\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,23]]},"references-count":177,"alternative-id":["10.3389\/fendo.2023.1217249"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1217249","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,23]]},"article-number":"1217249"}}